Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

FDA okays use of Engerix-B in patients with chronic HCV infection

Aug. 17, 1998

Results announced from primate studies of Nabi-Civacir

Aug. 17, 1998

New anti-H. pylori agents in development at Mitsubishi Chemical

Aug. 17, 1998

AU-006, a novel quinoline derivative with potent antiulcer activity

Aug. 14, 1998

Anti-H. pylori agents disclosed by Takeda

Aug. 12, 1998

Salofalk approved in Canada for the treatment of Crohn's disease

Aug. 12, 1998

Positive results reported from phase II trials of Provir for the treatment of watery diarrhea

Aug. 12, 1998

New agents for treating constipation presented at IUPHAR meeting

Aug. 11, 1998

Proton pump inhibitor IY-81149 is active in models of acute and chronic gastric ulcers

Aug. 10, 1998

Rabeprazole and teprenone combination therapy effective for gastric ulcers

July 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...